JUNE 6, 2024 | PALO ALTO, CA
Join Singular Genomics, Parse Biosciences, Miltenyi Biotec, and DeNovix for a series of seminars focused on the latest innovations in Single Cell and Spatial Biology.
The series of talks will start at 3:00pm and will be followed by happy hour from 5:00-6:30pm.
Stanford Medicine Research Park
3145 Porter Dr., Palo Alto, CA
Drew founded Singular Genomics in 2016 serving as the CEO and Chairman. Drew is a serial entrepreneur and venture investor in the biotech industry and has been involved in the founding of several successful companies. Prior to Singular Genomics, Drew founded Truvian Sciences, a low volume blood testing technology aimed at making routine blood tests easier, less invasive, and more affordable. Drew was also involved in the founding of Aspen Neurosciences where he co-led the seed financing and helped assemble a world-class team to combat Parkinson’s Disease using a patient’s own stem cells. Drew was also a seed investor and held an operating role in Edico Genome which sold to Illumina in 2018.
Drew received an MBA from the Rady School of Management at the University of California, San Diego and a BA in Political Science and International Relations from the University of California, San Diego.
